By Stewart Eisenhart, Emergo Group
The Drugs Controller General of India (DCG(I)), India’s medical device and pharmaceutical market regulator, has appointed a new head of its Medical Device Division as well as a new Joint Drugs Controller, which could lead to more efficient registration processes in the country.
First, Aseem Sahu has succeeded Dr. E. Reddy as head of DCG(I)’s Medical Device Division. In addition, Dr. V. G. Somani has been named Joint Drugs Controller at the Central Drugs Standard Control Organization’s head office in New Delhi.
According to Sunitha Singh, Regulatory Manager at Emergo Group’s Secunderabad office, these new DCG(I) appointments may cause short-term delays for Indian medical device market registrants, but will help provide more transparency and predictability over the longer term for manufacturers.
"These changes may lead to some delay in getting replies from the DCG(I) office, but in the long term this should have a positive influence," says Singh.
Stewart Eisenhart covers medical device regulatory affairs for Emergo Group.